Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Baliopharm AG
DescriptionHumanized mAb targeting tumor necrosis factor receptor 1 (TNFR1)
Molecular Target Tumor necrosis factor (TNF) receptor 1 (TNFRSF1A) (TNFR1) (CD120a)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today